Smoking Cessation Programs and their Impact on Reducing Pulmonary Cancer Risk


Rowling Lewis

Pulmonary Neuroendocrine Tumors (NETs) represent a diverse group of neoplasms arising from neuroendocrine cells in the respiratory tract. These tumors are relatively rare, accounting for only about 20% of all lung malignancies. Despite their rarity, managing pulmonary NETs presents unique challenges due to their heterogeneity, variable clinical behavior, and limited treatment options. Over the past few decades, significant progress has been made in understanding these tumors, leading to breakthroughs in diagnosis, classification, and treatment approaches. This article explores the challenges associated with managing pulmonary NETs and highlights the recent breakthroughs that are shaping the field.




arrow_upward arrow_upward